MR in ovarian cancer
- Conditions
- Ovarian cancerCancer
- Registration Number
- ISRCTN51246892
- Lead Sponsor
- Imperial College London (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 648
1. Written (signed and dated) informed consent* prior to mpMRI scan^ and judged capable of co-operating with study requirements during treatment and follow-up
2. Aged 18 years or over
3. Suspected ovarian, fallopian tube or primary peritoneal cancer. This can be contingent on imaging findings (either on ultrasound or CT) and/or a Risk Malignancy Index Score (RMI) greater than 250
4. Being considered for up-front surgery or for interval debulking surgery following neoadjuvant chemotherapy (after 3 to 5 cycles) via the NHS Cancer Pathway”
5. Considered fit for surgery (by MDT or patient’s surgeon)
*A patient can be enrolled based on verbal consent with written consent to be obtained prior to the mpMRI scan
1. Known contraindication to MRI (e.g. claustrophobia, ferrous implants, cardiac pacemaker, inability to lie flat)
2. Known pregnancy
3. Medical or psychiatric illness that renders the patient unsuitable or unable to give informed consent
4. Unable to undergo a CT scan with IV contrast due to allergy, renal failure or any other cause
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method